Eggert Stockfleth, MD, PhD

Professor of Dermatology
Head of Skin Cancer Center Charité
Vice-Chair of the Department of Dermatology, Venereology and Allergy
Charité – University Medical Center Berlin
Berlin, Germany



Eggert Stockfleth is Director of the Skin Cancer Center Charité, Berlin. He gained his medical degree in 1991 from the University of Hamburg and since then has held positions at a number of universities and institutions both in Germany (amongst others at the German Cancer Research Center Heidelberg) and the USA. He joined the University of Kiel in 1996 and in 1999 he was made Consultant of Dermatology, Venereology and Allergology. In 2001 he became University Professor at Charité – University Medical Center Berlin. Since 2004 he is the Head of the Skin Cancer Center Charité and since 2009 he is the Vice-chairman of Department of Dermatology, Venereology and Allergy.
He is a member of a number of professional associations including the Berlin Society of Dermatology, the German Society of Dermatology, the Hamburg Dermatology Association, the German Cancer Association, the German Dermatology Association, the European Academy of Dermatology and Venereology and the European Dermatology Forum. He is also the former European President of Skin Care in Organ Transplant Patients Network (SCOPE). In 2008 he was one of the founders of the European Skin Cancer Foundation, which aims to assist in developing and providing standardized treatments on a European level.

His research on dermatology, oncology and particularly skin cancer, has been extensively published in peer-reviewed journals. He acts as referee for many different journals including Journal of Infectious Diseases, International Journal of Cancer, Journal of Investigative Dermatology and The Lancet.

Research fields:
Dermatooncology, HPV-assoziated skin- and mucosal skin tumors, skin tumors in organ transplant patients, General dermatology, apoptosis regulation, skin carcinogenesis, Immunology, Tumorimmunology, molecular biology of skin tumors (melanoma, cutaneous lymphoma, cutaneous squamous cell carcinoma)